首页> 外文期刊>Chinese Jouranl of Integrative Medicine >Effects of Shenqi Fuzheng Injection on Changes of Matrix Metalloproteinases in Patients with Acute Myocardial Infarction
【24h】

Effects of Shenqi Fuzheng Injection on Changes of Matrix Metalloproteinases in Patients with Acute Myocardial Infarction

机译:参芪扶正注射液对急性心肌梗死患者基质金属蛋白酶变化的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To investigate the effects of Shenqi Fuzheng injection (SQFZI) on ventricular remodeling (VR) after acute myocardial infarction (AMI). Methods: Sixty patients with AMI were randomly divided into two groups and received conventional therapy and conventional therapy plus SQFZI separately. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-9 (TIMP-9) in plasma was measured on the 1st and 14th days after AMI. Results: MMP-9 and MMP-9/TIMP-9 were increased after AMI, after 2-week treatment, the level of MMP-9 and MMP-9/TIMP-9 decreased more significantly in SQFZI group than that in the conventional group (P<0.05). Conclusion: Early treatment with SQFZI after AMI could reduce the level of MMPs and the production of collagen. It may be useful for the prevention of VR and heart failure after AMI.
机译:目的:探讨参芪扶正注射液(SQFZI)对急性心肌梗死(AMI)后心室重构(VR)的影响。方法:将60例AMI患者随机分为两组,分别接受常规治疗和常规治疗加SQFZI。在AMI后第1天和第14天测量血浆中的基质金属蛋白酶9(MMP-9)和组织金属蛋白酶9抑制剂(TIMP-9)。结果:AMI后MMP-9和MMP-9 / TIMP-9升高,治疗2周后,SQFZI组MMP-9和MMP-9 / TIMP-9水平较常规组下降更为明显。 (P <0.05)。结论:AMI后早期用SQFZI治疗可降低MMP水平和胶原蛋白的产生。对于预防AMI后的VR和心力衰竭可能很有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号